{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-036995","form_type":"8-K","ticker":"SYRA","cik":"0001922335","company_name":"Syra Health Corp","filed_at":"2026-08-11T12:37:15+00:00","discovered_at":"2026-08-11T12:40:00.267118+00:00","generated_at":"2026-08-11T12:40:10.939366+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Syra Health posts Q2 2026 profit of $250K, revenue up 23% YoY to $2.4M","bullets":["Q2 2026 net income $250,242 vs net loss $(63,596) in Q2 2025; second consecutive profitable quarter.","Revenue grew 23% YoY to $2.4M; gross margin expanded to 44.5%, a company record, up from 38.7%.","EPS $0.02 vs $(0.01) loss; EBITDA turned positive at $253,200 vs $(53,760) in Q2 2025.","Healthcare workforce revenue jumped 87% YoY to $678,113; population health rose 8% to $1.7M.","Anticipates CMS ACCESS Model approval with HealthSync as potential 10-year revenue; cash $2.1M, no long-term debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-036995","json":"https://secwatch.observer/filing/0001493152-26-036995.json","markdown":"https://secwatch.observer/filing/0001493152-26-036995.md","text":"https://secwatch.observer/filing/0001493152-26-036995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922335/000149315226036995/0001493152-26-036995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922335/000149315226036995/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T12:40:10.939366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}